Literature DB >> 831622

Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark.

J Howitz, H Brodthagen, M Schwartz, K Thomsen.   

Abstract

The prevalence of vitiligo was 0.38% in 47,033 people in a representative region in Denmark. Both sexes were equally affected. No significant difference was found in the distribution of 179 patients with vitiligo among five municipalities or between urban and rural districts. The age-specific prevalence increased from 0.09% under the age of 10 years to 0.90% in the age group 60 to 69 years. After the age of 70, the prevalence declined. This fall might reflect an increased incidence of vitiligo during the past few decades. The number of new cases of vitiligo increased steadily with advancing age, its onset being most often between the ages of 40 and 60 years. It is assumed that the prevalence of vitiligo in Denmark applies also to the northwestern part of Europe.

Entities:  

Mesh:

Year:  1977        PMID: 831622     DOI: 10.1001/archderm.113.1.47

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  44 in total

1.  Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis.

Authors:  Richard A Spritz; Katherine Gowan; Dorothy C Bennett; Pamela R Fain
Journal:  Am J Hum Genet       Date:  2004-01       Impact factor: 11.025

Review 2.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

Authors:  Richard A Spritz
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

3.  A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families.

Authors:  Jian-Jun Chen; Wei Huang; Jin-Ping Gui; Sen Yang; Fu-Sheng Zhou; Quan-Geng Xiong; Hong-Bo Wu; Yong Cui; Min Gao; Wei Li; Jin-Xian Li; Kai-Lin Yan; Wen-Tao Yuan; Shi-Jie Xu; Jian-Jun Liu; Xue-Jun Zhang
Journal:  Am J Hum Genet       Date:  2005-04-04       Impact factor: 11.025

4.  TDP-43 frontotemporal lobar degeneration and autoimmune disease.

Authors:  Zachary A Miller; Katherine P Rankin; Neill R Graff-Radford; Leonel T Takada; Virginia E Sturm; Clare M Cleveland; Lindsey A Criswell; Philipp A Jaeger; Trisha Stan; Kristin A Heggeli; Sandy Chan Hsu; Anna Karydas; Baber K Khan; Lea T Grinberg; Maria Luisa Gorno-Tempini; Adam L Boxer; Howard J Rosen; Joel H Kramer; Giovanni Coppola; Daniel H Geschwind; Rosa Rademakers; William W Seeley; Tony Wyss-Coray; Bruce L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-30       Impact factor: 10.154

5.  Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality.

Authors:  S A Chambers; S C Charman; A Rahman; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2007-01-09       Impact factor: 19.103

6.  A genetical model for vitiligo.

Authors:  P P Majumder; S K Das; C C Li
Journal:  Am J Hum Genet       Date:  1988-08       Impact factor: 11.025

7.  Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus.

Authors:  S K Nath; J A Kelly; B Namjou; T Lam; G R Bruner; R H Scofield; C E Aston; J B Harley
Journal:  Am J Hum Genet       Date:  2001-10-08       Impact factor: 11.025

8.  Ocular abnormalities associated with cutaneous melanoma and vitiligolike leukoderma.

Authors:  M A Chang; G Fournier; H K Koh; A J Sober; H Nakagawa; T B Fitzpatrick; D M Albert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

9.  Vitiligo and disorders of the retinal pigment epithelium.

Authors:  D M Albert; M D Wagoner; R C Pruett; J J Nordlund; A B Lerner
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

10.  Genetic epidemiology of vitiligo: multilocus recessivity cross-validated.

Authors:  S K Nath; P P Majumder; J J Nordlund
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.